ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $278.63M in the quarter ending September 30, 2025, with 11.27% growth. This brings the company's revenue in the last twelve months to $1.05B, up 12.69% year-over-year. In the year 2024, ACADIA Pharmaceuticals had annual revenue of $957.80M with 31.85% growth.

• Revenue (ttm): $1.05B
• Revenue Growth: +12.69%
• P/S Ratio: 4.34
• Revenue / Employee: $1,601,098
• Employees: 654
• Market Cap: 4.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	957.80M	231.36M	31.85%
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%
Dec 31, 2019	339.08M	115.27M	51.50%
Dec 31, 2018	223.81M	98.91M	79.19%
Dec 31, 2017	124.90M	107.57M	620.68%
Dec 31, 2016	17.33M	17.27M	28,311.48%
Dec 31, 2015	61.00K	-59.00K	-49.17%
Dec 31, 2014	120.00K	-1.03M	-89.52%
Dec 31, 2013	1.15M	-3.76M	-76.67%
Dec 31, 2012	4.91M	2.84M	137.40%
Dec 31, 2011	2.07M	-40.07M	-95.09%
Dec 31, 2010	42.14M	35.74M	558.46%
Dec 31, 2009	6.40M	4.81M	302.45%
Dec 31, 2008	1.59M	-5.97M	-78.95%
Dec 31, 2007	7.56M	-578.00K	-7.11%
Dec 31, 2006	8.13M	-2.82M	-25.77%
Dec 31, 2005	10.96M	-	-